INTRODUCTION
an optimal use of hepatocytes. In a previous work, we demonstrated that hepatocytes preserved in University of Wisconsin solution up to 96 h engraft in the liver and Cell-based therapies have been developed as an alternative to whole-organ transplantation for the treatment function in a manner comparable with freshly isolated hepatocytes (22), allowing a better use of liver cells. of liver disorders. The clinical application of hepatocyte transplantation (HTx) is increasingly envisioned as tem-Regarding the site of injection, the most frequent routes are direct injection into portal vein (clinical re-porary metabolic support during acute liver failure, for long-term metabolic supplementation in chronic liver in-search) or into spleen parenchyma (preclinical research), where hepatocytes integrate and support liver functions sufficiency, and in hepatocyte-directed ex vivo gene therapy (6, 23) . Clinical improvement has been demon-displaying long-term survival (1, 10, 11, 23) . Ectopic sites for hepatocyte transplantation, as intraperitoneal or sub-strated after HTx in humans with selected inherited liver disorders, where long-term function and survival of do-cutaneous injections, delay the entry of hepatocytes into the liver and involve a substantial cell loss (9) . On the nor hepatocytes were observed (16) . However, it is difficult to asses whether HTx alone could provide support other hand, a rat model with the spleen in a subcutaneous position allowed multiple splenic injections of hepa-to recovery in patients with acute hepatic failure (23). HTx allows the use of livers that are discarded for ortho-tocytes in a safe procedure (2). Many patients may require a large number of engrafted cells for therapeutic topic liver transplantation (OLT), alleviating, in part, the shortage of organ donors. This methodology presents effect and this could be achieved by multiple HTx but would expose receptors to an unacceptable risk of portal much less morbidity and several patients could receive cells from a single donor. However, the site of injection, hypertension (5, 18, 23) . Attempts to engraft a significant number of cells in the source of hepatocytes, and the mass injected are limiting factors in this procedure (5, 16) .
the liver parenchyma in experimental animals using a single injection into the spleen or portal vein have re-New technologies developed to maintain cells allow 776 SIGOT ET AL. sulted in death, mainly due to acute portal vein thrombo-TRIS and 0.5 mM EGTA, pH 7.40, at 37°C. The perfusate was oxygenated while passing through oxygen-sis, pulmonary embolism, and intractable shock (3). However, hepatocyte transplantation in the spleen with permeable tubing (Silicone Tubing, Baxter Healthcare Corp., Deerfield, IL) inside an appropriate glass con-complete and temporary occlusion of splenic vessels prevented massive embolization in cirrhotic rats (13) . In tainer filled with carbogen (95% O 2 /5% CO 2 ) at a constant pressure of 90 mmHg. Air bubbles were avoided a previous work, Gupta et al. demonstrated that hepatocytes transplanted in the rat spleen enter sinusoids at 2 by connecting a disposable Nylon filter in line between the oxygenator and the inflow. After the initial flushout, h and translocate into liver plates between 16 and 20 h after transplantation. Unfortunately only a fraction of the perfusion was followed in a recirculating buffer system with 150 ml of EGTA-free HBSS supplemented transplanted hepatocytes (<20-30%) survived in the liver (8, 17) . The potential of vasodilatory drugs to mod-with 1.2 mM CaCl 2 , 0.01% collagenase type IV, and 1% bovine serum albumin (BSA). The cell suspension was ulate portal and or splanchnic blood flow has been studied to promote greater and distal transplanted cell entry.
centrifuged (54 × g for 3 min) and the pellet was resuspended twice in HBSS/1% BSA/1.2 mM CaCl 2 solution. Intrasplenical infusion of nitroglycerine before, during, and 10 min after hepatocyte injection improved cell en-Cell viability was tested by the exclusion of trypan blue stain (TBE) in phosphate-buffered saline (PBS). Greater graftment, restoring hepatic microcirculation after cell transplantation (21) . than 700 million cells were obtained per liver. A TBE higher than 80% was considered suitable for the experi-Sodium nitroprusside (SNP), a potent hypotensive agent, produces peripheral vasodilatation and is more ments. The isolated cell suspensions used for transplantation studies were judged to be 95% hepatocytes by active on veins than on arteries; it must be used with caution as nitroprusside injection can result in toxic lev-morphological examination (22). els of cyanide (15) . When added during reperfusion, it
Hepatocyte Labeling improves posttransplantation function of lung allografts in dogs (24) . Also, the addition of sodium nitroprusside A stock solution (3.6 mM) of 5(6)-carboxyfluorescein diacetate succinimidyl-ester (CFSE; Cat. # C1157, during liver preservation improves rat liver hemodynamics and functions after cold storage (19).
Molecular Probes, Inc. Eugene, OR) was prepared in 100% dimethyl sulfoxide and stored at −20°C. Based on the ability of SNP to modulate portal flow, we decided to investigate the effect of SNP in the migra-Isolated hepatocytes (5 × 10 6 cells/ml) were suspended in HBSS solution containing 20 µM CFSE and tion of hepatocytes into the rat liver when both are injected simultaneously in the spleen. Identification and incubated for 20 min at 37°C under carbogen atmosphere in a Dubnoff metabolic shaker. After labeling, quantification of transplanted cells were achieved using the fluorescent dye, 5(6)-carboxyfluorescein diacetate the cells were washed twice with HBSS (20) , and viability was measured before transplant. succinimidyl-ester, which is stable and specific for hepatocytes (7, 22) .
Arterial and Portal Pressure Measurements MATERIALS AND METHODS SNP was provided by Merck (Darmstadt, AG Ger-Animals many). SNP was dissolved in HBSS to obtain a dose of 24 nmol/100 g b.wt. (SNP 24 ) and injected in the spleen, Adult male Wistar rats weighting 280-310 g were alone or added into the hepatocyte suspension, immedihoused in controlled environmental conditions under a ately before HTx, in a final volume of 0.7 ml. 12-h light/dark cycle and provided with water and stan-Animals were anesthetized with sodium thiopental dard rat chow ad lib. The animal care and the experi-(70 mg/kg, IP) and placed on a thermostatized surgical mental model were performed in accordance with intertable to maintain body temperature at 37.0°± 1.0°C. national regulations and guidelines from the School of Arterial and portal pressures were determined with Biochemical and Pharmaceutical Sciences, National two pressure transducers connected to a transducer am-University of Rosario, Argentina. All operations were plifier (Transbridge TBM4M World Precision Instruperformed between 0900 and 1200 h and two to four ments, Inc., Miami, FL). The femoral artery was cananimals were used for each experiment.
nulated with a catheter (Intramedic P40) flushed with Hepatocyte Isolation heparinized saline solution to measure the blood arterial pressure. Portal pressure was measured by two methods: Hepatocytes were isolated by collagenase perfusion, based in a procedure described by Seglen and modified 1) by direct puncture of the spleen with a 23-gauge needle; after insertion in the red pulp of the spleen, the nee-by us (20, 22) . Briefly, livers were perfused in situ for 5 min via portal vein with 100 ml of a modified Hanks' dle was fixed with surgical glue and connected to a catheter filled with heparinized saline solution; or 2) by balanced salt solution (HBSS) supplemented with 5 mM placing a Teflon catheter (22-gauge × 1 in., Terumo Sur-rescent hepatocytes adjacent to portal spaces were observed at 1, 3, and 6 h compared with larger foci ob-flo) in the gastric vein and conducting it toward the portal vein, thereby avoiding to tie off the portal circulation.
served at 24 h after Htx. Figure 2 shows the time course of the migration of Both techniques gave comparable results. The spleen was then gently exposed with minimal handling and a transplanted hepatocytes quantified as fluorescent areas in at least 15 random areas per control and SNP 24 -treated 10-min stabilization period was allowed before intrasplenic injections. The zero point for all pressure trans-animals. At 1 h after HTx there were no significant differences ducers was set to the level of the right heart.
in the fraction of fluorescent areas between control and Experimental Groups and Transplantation Procedure treated animals. At 3 h, the median fraction of fluores-Untreated Wistar rats were used as recipients for cent areas (transplanted hepatocytes) observed in the left HTx. Animals were transplanted with freshly isolated liver lobe in the SNP 24 -treated group was 4.4% (range hepatocytes suspended in HBSS (controls) or with hepa-3.7-5.1%) versus a median fraction in the control group tocytes suspended in HBSS + SNP (SNP 24 -treated group). of 2.5% (range 1.6-3.2%); at 6 h the SNP 24 -treated These suspensions were injected into the inferior pole of group median fraction was 1.1% (range 0.5-2.4%) verthe spleen using a 25-gauge needle. The site of injection sus 0.2% (range: 0.1-0.9%). At 24 h fluorescent areas was sealed to prevent bleeding and cell leakage. The cell were rare in controls (median 0%) whereas they were viability assessed after labeling and prior HTx ranged more frequent in treated animals (median 1.0%; range from 80% to 87% by TBE, and the mass injected varied 0-6.0%). These data were obtained from two indepenbetween 30 and 40 × 10 6 hepatocytes. The effect of SNP dent experiments at each time ( p < 0.05, Mann-Whitney was evaluated at 1, 3, 6 
, and 24 h posttransplant by mortest). phometric analysis of transplanted cells. Left liver lobe
Although the overall number of transplanted cells in sections were collected at the different times, fixed in the liver substantially diminished from 3 to 24 h, hepato-10% formaldehyde buffered in PBS, and embedded in cyte mass was larger in the SNP 24 -treated animals comparaffin. Samples stained with hematoxylin and eosin pared with controls at all times post-HTx. This indicated were examined under light microscopy and transplanted that SNP vasodilatation had a direct role in the early hepatocytes were localized under fluorescence microsmigration of a large number of cells from the spleen to copy. Image analysis was performed in a minimum of the liver. 15 random areas from each liver sample. Each sample
Response of Portal and Arterial Pressure was photographed under 10× magnification in a NIKON
to Intrasplenic Injection of SNP XBA microscope equipped with SPOT image processor and a SPOT RT camera. The area of each microscopic
To establish if the improvement on hepatocyte migrafield was settled in 1212 × 909 µm. The percentage area tion was related to the vasodilatation process, we meaof the liver section occupied by green fluorescent donor sured portal and arterial pressure changes during HTx in cells was determined by computer-assisted image analythe presence of SNP 24 . sis using Image Pro-Plus (Image Processing System, Figure 3 shows that an intrasplenically injected dose Version 2.0). of SNP resulted in a significant, but transient, drop in arterial pressure while a progressive and sustained dimi-Statistical Analysis nution was observed in portal pressure. Mean arterial Due to small sample sizes and frequently nonnormal pressure dropped from 129 ± 14 mmHg (baseline value) distribution of data, differences for transplanted hepatoto 46 ± 3 mmHg (n = 3, p < 0.05) and portal pressure cytes were analyzed with the Mann-Whitney test, with diminished from 9.4 ± 3.0 to 6.1 ± 0.5 mmHg (n = 3, p < a value of p < 0.05 considered significant. 0.05). The systemic pressure returned to the basal values Differences on portal pressure measurements were within 5 min, while portal pressure remained lower than analyzed by covariance analysis to compare data in basal value until the end of experiments. basal state with values after intrasplenic injection of Effect of Simultaneous Injection of SNP SNP 24 dose, or after HTx in controls and SNP 24 -treated and Hepatocytes on Portal Pressure During HTx animals. A value of p < 0.05 was considered significant.
We recorded the evolution of portal pressure after in-RESULTS jecting either 30 × 10 6 hepatocytes (control group) or Distribution of Transplanted Cells SNP + hepatocytes (SNP-treated group). Figure 4 shows the temporal profile of portal pressure measured through Figure 1 shows the representative distribution of transplanted cells after 24 h of injection of hepatocytes the gastric vein. In both groups a raise in portal pressure was rapidly observed during the first minute ( p < 0.05) in control and SNP 24 -treated animals. Small foci of fluo- and then the pressure was stabilized at a value signifi-To integrate to the liver, transplanted hepatocytes should translocate the barrier of hepatic sinusoidal endo-cantly higher than baseline. The control group showed a baseline value of 7.8 ± 2.8 mmHg and final value of thelium. To facilitate this translocation, Gupta and colleagues (12) produced a prior disruption of sinusoidal 10.9 ± 1.2 mmHg. The SNP-treated group showed a baseline value of 7.3 ± 0.9 mmHg and a final value of endothelium with ciclophosphamide, allowing more cells to leave the hepatic sinusoids to enter the liver plate, 11.2 ± 1.1 mmHg (n = 4 each group, p < 0.05). There was no significant difference in portal pressure change and demonstrated that greater initial entry of cells into liver plates facilitates further integration and repopula-between groups.
tion. However, ciclophosphamide toxicity limits their DISCUSSION application in human HTx. In our study, we used the vasodilatory drug SNP dur-Our findings indicated that addition of SNP at a dose of 24 nmol/100 g b.wt. in the hepatocyte suspension ing hepatocyte transplantation to enlarge the number of hepatocytes entering the liver without physical disrup-prior to transplantation in the spleen resulted in a greater engraftment of cells into the liver.
tion of the sinusoidal endothelium. The SNP concentra- tion in the suspension cell was nontoxic (14) . Injection tion of SNP and hepatocytes will allow a greater initial entry of cells to the liver sinusoids through portal vein in the spleen of SNP was performed in a maximum of 45 s and was followed by an immediate and progressive dilatation.
The mass of hepatocytes observed in the liver at 3, diminution in portal pressure during at least 10 min. These findings may support that the simultaneous injec-6, and 24 h after HTx was significantly higher compared with controls at the same times without SNP treatment. portal pressure was maintained higher than baseline but almost in the normal range, showing portal flow distur-We observed that the transient vasodilatory effect of SNP at a dose of 24 nmol/100 g b.wt. is sufficient to bances by cell migration. Although additional work is clearly necessary, the significantly improve the mass of transplanted hepatocytes in the liver on or after 3 h and up to at least 24 h. study provides a simple and useful method to deliver a higher mass of hepatocytes by a single dose in a safe Although we were not able to show a difference at 1 h after cell transplantation because transplanted hepato-surgical procedure. In addition, this method avoids pretreatment with the vasodilatory drug, reducing the surgi-cytes are mainly in portal veins at that earlier time and we only evaluated random areas in the left liver lobule. cal procedure to a single injection lasting over 45 s. Whether SNP treatment will translate into greater liver However further evaluation of portal spaces during the first 60 min after hepatocyte injection could provide un-repopulation needs further studies. The success of therapeutic hepatocyte transplantation derstanding about the initial entry of cells in our experimental conditions. should promote rapid and early delivery of cells after a hepatotoxic insult to accelerate liver repopulation. Although the cell mass decreased drastically within 24 h, which agree with previous observations (4), the 
